AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 62 min read$MCK

McKesson, CD&R to Buy Option Care Health in $5.8 Billion Deal

McKesson Corp. and Clayton Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake. Option Care shares surged 20% overnight, halted before trading. The deal, at a 37% premium, is expected to close in 2027.

Original reporting
finance.yahoo.com
Published Oct 6, 2026, 12:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefMergers & acquisitions
Primary signal
$MCK
Neutral
high confidence
Mentioned
$MCK · $OPCH
Relevance
9/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$MCKNeutralHigh
01

Why it matters

The deal adds a strategic asset for McKesson while providing Option Care shareholders a premium exit.

02

Market read

The announcement drives immediate price moves and signals continued consolidation in the healthcare services sector.

03

What to watch

Regulatory approval risk and integration challenges could delay value realization.

Relevance 9/10Novelty 9/10Timing: today

Background

The acquisition expands McKesson's footprint into the medical infusion market, a growing segment of specialty care.

Company-level read

Ticker impact

$MCKNeutralHigh confidence
Context

McKesson announced a $5.8B acquisition of Option Care Health, investing $1.4B for a 49% stake.

Expected impact

potential slight downside as investors price the $1.4B cash investment

Evidence & confidence

The deal size is material but the market typically reacts cautiously to large acquisitions that require significant capital.

$OPCHBullishHigh confidence
Context

Option Care Health shares were halted then surged >20% after the $5.8B acquisition announcement with a 37% premium.

Expected impact

upward pressure as the market prices in the 37% premium and deal completion

Evidence & confidence

The announced premium and immediate 20% jump indicate strong buyer enthusiasm; the deal is expected to close in H1 2027.

Market effects

Sector

Healthcare services consolidation may boost valuations of other infusion and specialty pharmacy providers.

Regional

U.S. healthcare M&A activity could see heightened investor interest.

Global

Large U.S. healthcare deals influence global pharma and biotech investment sentiment.

Counterpoint

What could challenge this read

Some investors may view the cash outlay as overpaying, risking dilution of McKesson's balance sheet.

Key entities

  • Company
    McKesson Corp.

    U.S. healthcare services and distribution giant.

  • Company
    Option Care Health Inc.

    Provider of home and alternate site infusion services.

  • Private Equity
    Clayton Dubilier & Rice

    PE firm taking majority ownership of Option Care.

Read at source← All news

Also covered by

4 outlets

Related articles

OCT 7
$MCKHighAI 9/10

McKesson, private equity firm buy home infusion company, Option Care Health

McKesson Corporation and private equity firm Clayton Dubilier & Rice (CD&R) agreed to acquire Option Care Health, a home infusion company, for $5.8 billion. McKesson will invest $1.4 billion for a 49% stake, with CD&R taking 51%. The deal values Option Care Health at $32.05 per share, a 36% premium over Monday's closing price. Once completed, Option Care Health will become private and delist from Nasdaq.

managedhealthcareexecutive.com2 min
OCT 7
$LWHighAI 8/10

US Stock Movers: Lamb Weston, Option Care, Apogee Rally

Lamb Weston (LW) shares rose 11.85% after reporting Q1 sales of $1.67B and raising 2027 EBITDA guidance. Option Care (OPCH) jumped 32.8% on a $5.8B take-private deal. Apogee (APOG) gained 18.7% on strong Q2 earnings and raised FY2027 outlook. Constellation (CEG) surged 14.79% after a Google nuclear deal. RPM (RPM) rose 2.5% on record Q1 results.

hdfcsky.com2 min
OCT 7
$MCKHighAI 9/10

McKesson, CD&R to Buy Option Care for $5.8B

McKesson Corp. and private equity firm Clayton, Dubilier & Rice will acquire Option Care Health Inc. for $5.8 billion, or $32.05 per share, a 37% premium. McKesson will own 49%, with CD&R as the controlling shareholder. Option Care, a major provider of home and outpatient infusion care, will retain its management team. The deal aligns with McKesson's strategy to expand specialty care services, potentially increasing its ownership over time.

briefs.co2 min
OCT 6
$OPCHHighAI 9/10

Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid

Option Care Health (OPCH) surged 33% to $31.11 after announcing a $5.8B acquisition by CD&R and McKesson at a 37% premium. The deal, expected to close in 2027, values OPCH at $32.05 per share. The company will delist from Nasdaq. Hedge fund holdings fell 42% QoQ despite more funds establishing positions. Q3 earnings, due Nov 4, 2026, will not include guidance.

finance.yahoo.com2 min